Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TANYA SIDDIQI

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1467408948
CMS profile
156689
Location
DUARTE, CA

General Payments · PY2018–2024

$237,105.97

  • Reported across 218 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$35,832.28

27 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $12,141.54 6
Celgene Corporation $12,094.85 4
Acerta Pharma LLC $6,119.59 13
Genmab U.S., Inc. $5,476.30 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $42,979.52 54
PY2019 $47,638.13 41
PY2020 $30,468.77 19
PY2021 $21,477.81 19
PY2022 $26,093.84 21
PY2023 $32,615.62 37
PY2024 $35,832.28 27

Payment records · PY2024 (27)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $300.00 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104372923 CMS
AstraZeneca Pharmaceuticals LP $124.25 04/16/2024 Food and Beverage Undisputed 01/23/2026 1105731269 CMS
AstraZeneca Pharmaceuticals LP $2,200.00 04/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105878513 CMS
AstraZeneca Pharmaceuticals LP $74.68 07/13/2024 Food and Beverage Undisputed 01/23/2026 1104295182 CMS
AstraZeneca Pharmaceuticals LP $16.29 07/13/2024 Food and Beverage Undisputed 01/23/2026 1104617914 CMS
AstraZeneca Pharmaceuticals LP $359.65 07/13/2024 Travel and Lodging Undisputed 01/23/2026 1105254734 CMS
AstraZeneca Pharmaceuticals LP $65.00 07/13/2024 Travel and Lodging Undisputed 01/23/2026 1105446097 CMS
AstraZeneca Pharmaceuticals LP $43.78 07/13/2024 Food and Beverage Undisputed 01/23/2026 1105606145 CMS
AstraZeneca Pharmaceuticals LP $2,497.50 07/22/2024 Consulting Fee Undisputed 01/23/2026 1105703422 CMS
AstraZeneca Pharmaceuticals LP $103.44 08/08/2024 Food and Beverage Undisputed 01/23/2026 1104633351 CMS
AstraZeneca Pharmaceuticals LP $100.00 10/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105397490 CMS
AstraZeneca Pharmaceuticals LP $100.00 10/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105589194 CMS
AstraZeneca Pharmaceuticals LP $135.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 1105345810 CMS
Celgene Corporation $474.46 06/12/2024 Travel and Lodging Undisputed 01/23/2026 1101107592 CMS
Celgene Corporation $10,669.80 06/13/2024 Travel and Lodging Undisputed 01/23/2026 1101107590 CMS
Celgene Corporation $474.46 06/13/2024 Travel and Lodging Undisputed 01/23/2026 1101107594 CMS
Celgene Corporation $476.13 07/11/2024 Food and Beverage Undisputed 01/23/2026 1101107600 CMS
E.R. Squibb & Sons, L.L.C. $3,460.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 1101317190 CMS
E.R. Squibb & Sons, L.L.C. $3.46 06/13/2024 Food and Beverage Undisputed 01/23/2026 1101317230 CMS
E.R. Squibb & Sons, L.L.C. $8,152.00 07/09/2024 Consulting Fee Undisputed 01/23/2026 1101317204 CMS
E.R. Squibb & Sons, L.L.C. $96.19 07/11/2024 Food and Beverage Undisputed 01/23/2026 1101317212 CMS
E.R. Squibb & Sons, L.L.C. $379.94 07/11/2024 Travel and Lodging Undisputed 01/23/2026 1101317214 CMS
E.R. Squibb & Sons, L.L.C. $49.95 12/08/2024 Food and Beverage Undisputed 01/23/2026 1101317268 CMS
Genmab U.S., Inc. $253.73 09/24/2024 Travel and Lodging Undisputed 01/23/2026 1126832675 CMS
Genmab U.S., Inc. $39.86 09/25/2024 Travel and Lodging Undisputed 01/23/2026 1126832673 CMS
Genmab U.S., Inc. $5,102.50 09/25/2024 Consulting Fee Undisputed 01/23/2026 1126832677 CMS
Genmab U.S., Inc. $80.21 09/25/2024 Food and Beverage Undisputed 01/23/2026 1126832679 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.